RT Journal Article
SR Electronic
T1 Functional and microstructural brain abnormalities, fatigue, and cognitive dysfunction after mild COVID-19
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.03.20.21253414
DO 10.1101/2021.03.20.21253414
A1 Silva, Lucas Scardua
A1 Joao, Rafael Batista
A1 Nogueira, Mateus Henrique
A1 Aventurato, Italo Karmann
A1 de Campos, Brunno Machado
A1 de Brito, Mariana Rabelo
A1 Alvim, Marina Koutsodontis Machado
A1 Ludwig, Guilherme Vieira Nunes
A1 Rocha, Cristiane
A1 Souza, Thierry Kaue Alves Silva
A1 da Costa, Beatriz Amorim
A1 Mendes, Maria Julia
A1 Waku, Takeshi
A1 de Oliveira Boldrini, Vinicius
A1 Brunetti, Natália Silva
A1 Baptista, Sophia Nora
A1 Schmitt, Gabriel da Silva
A1 de Sousa, Jhulia Gabriela Duarte
A1 de Oliveira Cardoso, Tânia Aparecida Marchiori
A1 Vieira, André Schwambach
A1 Santos, Leonilda Maria Barbosa
A1 Farias, Alessandro dos Santos
A1 Cendes, Fernando
A1 Yasuda, Clarissa Lin
YR 2021
UL http://medrxiv.org/content/early/2021/12/06/2021.03.20.21253414.abstract
AB Although post-acute cognitive dysfunction and neuroimaging abnormalities have been reported after hospital discharge in patients recovered from COVID-19, little is known about persistent, long-term alterations in patients who did not require hospitalization. Therefore, we conducted a cross-sectional study of 87 consecutive, non-hospitalized recovered individuals, with a median of 54 days after the laboratory confirmation of COVID-19. We performed structured interviews, neurological examination, and 3T-MRI scans. The MRI study included white matter investigation with diffusion tensor images (DTI) and seed-based resting-state functional MRI (fMRI) connectivity analyses of the default mode network (DMN). In addition, we used validated instruments to examine fatigue, symptoms of anxiety and depression, somnolence, language, memory, and cognitive flexibility.Individuals self-reported a high frequency of headaches (40%) and memory difficulties (33%). The quantitative analyses confirmed symptoms of fatigue (68% of participants), excessive somnolence (35%), symptoms of anxiety (29%), impaired cognitive flexibility (40%) and language dysfunction (33%). In addition, we observed a correlation between DTI fractional anisotropy (FA) and abnormal attention and cognitive flexibility measured by the Trail Making Test part B. The resting-state fMRI study of the DMN showed an association between higher connectivity of the posterior cingulate cortex (PCC) and higher levels of fatigue and somnolence. While greater connectivity of the PCC with bilateral angular gyri was associated with higher fatigue levels, the elevated levels of somnolence correlated with higher connectivity between the PCC and both the left thalamus and putamen.Competing Interest StatementThe authors declare they have no competing financial interests related to this study.Clinical TrialThere is no intervention in our study.Funding StatementThis study was funded by FAPESP-BRAINN (2013/03557-9), FAPESP (2019/11457-8), FAPESP (2019/233160), FAPESP (2020/04032-8); CAPES (Coordination of superior level staff improvement provided scholarship for Dr. Lucas Scardua Silva).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Research Ethics Committee of the University of Campinas (Certificate of Ethical Appreciation Presentation - CAAE 31556920.0.0000.5404), and all subjects signed a consent form to participate.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData collected and analyzed for this study will be available at the University database. Neuroimaging raw data will be available upon reasonable request.